Clinical Trial Update: Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions [NA]

View source ↗

Summary

Post-market study update for the ZENFLEX Pro Stent evaluating its use in femoropopliteal artery lesions; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• ZENFLEX Pro Stent

Snippet

Sponsor: Zhejiang Zylox Medical Device Co., Ltd. | Conditions: Peripheral Arterial Disease | NA | Status: NOT_YET_RECRUITING